OC-064 Pet Scanning in Gastric Cancer: a Comparison Of Avid Versus Non Avid Cancers
نویسندگان
چکیده
منابع مشابه
Simultaneous visualization of FDG avid and non-avid metastases in renal cell cancer.
Fig. 1. The PET/CT scan was performed 70 min after intravenous injection of 363 MBq (9.8 mCi) of F-FDG. Maximum intensity projection (A), axial PET (B, E), PET/CT fusion (C, F) and CT (D, G) at level of upper abdominal and thoracic images showed a large right adrenal mass (60 × 45 mm dimensions, 44 HU) without any significant FDG uptake (SUVmax: 1.8) (open arrows) and increased FDG uptake in a ...
متن کاملFollicular thyroid cancer avid on C-11 Methionine PET/CT
A case of follicular thyroid cancer with intense focal Methionine uptake on 11C-Methionine PET/CT is reported here. The use of 11C-Methionine PET in differentiated thyroid cancer is currently being investigated as a surrogate tracer compared to the more widely used 18F-FDG PET. This case illustrates the potential incremental value of this modality, not only in the localizing of parathyroid aden...
متن کامل18F-NaF Positive Bone Metastases of Non 18F-FDG Avid Mucinous Gastric Cancer
Detection of gastric cancer bone metastasis is crucial since its presence is an independent prognostic factor. In this case report, we would like to present 18F-NaF positive bone metastases of non 18F-FDG avid gastric mucinous cancer.
متن کاملTechniques Radio-guided Surgery for Non-I-avid Thyroid Cancer
Objective: In this paper we report in a larger series the use of radio-probe-guided surgery (RGS) in nonradioiodineavid, well-differentiated thyroid cancer (DTC). Design: Thirty-seven patients with locoregional recurrent, nonradioiodine avid DTC were studied with Tc-sestamibi directed RGS using a handheld gamma probe as an intraoperative detector. Outcome: Twenty-three women and 14 men were fol...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Gut
سال: 2013
ISSN: 0017-5749,1468-3288
DOI: 10.1136/gutjnl-2013-304907.063